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Abstract Next-generation sequencing (NGS) machines can
sequence millions of DNA strands in a single run, such as
oligonucleotide (oligo) libraries comprising millions to tril-
lions of discrete oligo sequences. Capillary electrophoresis is
an attractive technique to select tight binding oligos or
“aptamers” because it requires minimal sample volumes
(e.g., 100 nL) and offers a solution-phase selection environ-
ment through which enrichment of target-binding oligos can
be determined quantitatively. We describe here experiments
using capillary transient isotachophoresis (ctITP)-based non-
equilibrium capillary electrophoresis of equilibrium mixtures
(NECEEM) as a method for selecting aptamers from a ran-
domized library containing a known (29mer) thrombin-
binding aptamer. Our capillary electrophoresis (CE)-selected
samples were sequenced by the Ion Torrent Personal Genome
Machine (PGM) and analyzed for selection efficiency. We
show that a single round of CE selection can enrich a
randomer synthetic DNA oligo mixture for thrombin-
binding activity from 0.4 % aptamer content before selection
to >15 % aptamer content.
Keywords Separations . Instrumentation . Capillary
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Abbreviations
CE Capillary electrophoresis
ctITP Capillary transient isotachophoresis
ECEEM Equilibrium capillary electrophoresis of equilib-
rium mixtures
emPCR Emulsion polymerase chain reaction
KCE Kinetic capillary electrophoresis
NECEEM Nonequilibrium capillary electrophoresis of
equilibrium mixtures
NGS Next-generation sequencing
PGM Personal Genome Machine
SELEX Systematic evolution of ligands by exponential
enrichment
Introduction
Here, our purpose is to demonstrate how to 1) optimize
aptamer selection using capillary transient isotachophoresis
(ctITP)-based nonequilibrium capillary electrophoresis of
equilibrium mixtures (NECEEM) and to 2) quantify and an-
alyze aptamer selection using the Ion Torrent Personal Ge-
nome Machine (PGM). We demonstrated our combination of
capillary electrophoresis (CE) and next-generation sequencing
(NGS) using the 29-nucleotide thrombin aptamer “29mer”
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that binds thrombin protein. This new combination of meth-
odologies can be extended to yet undiscovered aptamers.
CE is a powerful separation technique. Recently, novel
kinetic CE (KCE) techniques, such as NECEEM, have been
used to select aptamers from randomer libraries [1, 2], im-
proving over traditional systematic evolution of ligands by
exponential enrichment (SELEX) [3, 4] in speed and sample
conservation.
This work uses NECEEM [5, 6] to separate aptamer-target
complexes from oligo libraries that contain one target-binding
aptamer. In NECEEM, the target and oligo library interact in
solution prior to electrophoretic separation. We have recently
demonstrated improvements onNECEEMby developing new
fluorescent derivatization techniques for labeling of oligonu-
cleotide libraries and also by using capillary transient
isotachophoresis, ctITP, to improve resolution of aptamer-
target complexes from the bulk library [7]. In ctITP, leading
and terminal ions (which have mobilities greater than or less
than the analyte, respectively) are used to first focus the
analyte band as in traditional isotachophoresis, and then as
the ions eventually de-stack, the analytes are separated as in
traditional capillary zone electrophoresis (CZE) [8]. In this
work, a leading ion was added to the sample buffer and a
terminal ion was added to the separation buffer.
Five conditions should be met to optimally combine CE
and NGS for aptamer selection. First, oligo libraries must be
prepared with DNA “handles” (flanking adaptor sequences
for amplification and sequencing) that do not interfere with
aptamer folding. Second, the reaction mixture applied to the
capillary must contain purified target and at least one oligo
species (aptamer) with sufficiently high target-binding affinity
to allow separation of the aptamer-target complex from non-
binding species. Third, the separated aptamer-target complex
should be detectable, which we addressed through improved
separation and labeling methods [7] (see also Experimental
section) to enable detection of 10 femtograms (fg) of single-
stranded DNA. Fourth, each CE collected fraction requires
sufficient DNA to avoid excessive cycles of PCR, which can
result in amplification artifacts such as long DNA
concatemers (data not shown). Fifth, all NGS systems require
sophisticated data analysis. The PGM is known to make base-
calling errors for long homopolymer sequences [9], a limita-
tion we addressed through data filtering.
With these conditions in mind, we combined CE and NGS
to select the 29mer thrombin aptamer spiked into a library
with ∼1015 unique oligonucleotides. Our proof-of-concept
study established the following: (i) ctITP aptamer selection
and enrichment can be quantified by NGS, (ii) the aptamer
fraction can be enriched >40-fold following a single round of
ctITP selection, and (iii) any potential secondary structure of
the quadruplex-forming thrombin aptamers does not
seriously impede Ion Torrent NGS sequencing. Additionally,
our work established that NGS sequencing by the Ion Torrent
PGM is reproducible from run to run and is independent of
sequencing chip size, automated emulsion PCR in the Ion One
Touch system, and enrichment. We have also established that
the addition of co-ions (K+, Na+, and Mg2+) decreased our
ability to select the thrombin aptamer against a randomer
library due to a decrease in complex formation as well as a
deterioration in separation resolution as seen in other labs
[10].
Experimental
We present a schematic of the experimental workflow in
Fig. 1. The basic steps are to start by mixing a ssDNA aptamer
library (spiked 29mer randomer; for details about the 29mer
randomer, see the supplement) with the target (thrombin) and
then separate the aptamer-target complex using CE. Next,
sequence the pre-injected “original” aptamer-target “com-
plex” and unbound-“free” DNA samples with subsequent
bioinformatics analysis.
Chemicals and reagents
We purchased tris (hydroxymethyl) amino methane (Tris) and
glycine (Gly) from Sigma (St. Louis, MO); SYBR Gold,
Dynabeads MyOne Streptavidin C1, Ion PGM Template
OT2 200 Kit, Ion Sphere Quality Control Kit, Ion PGM
Sequencing 200 Kit v2, Ion 314 Chip Kit v2, and Ion 316
Chip Kit from Life Technologies (Carlsbad, CA); human α-
thrombin from Enzyme Research Laboratories (South Bend,
IN), DNA samples and Ion Torrent primers (including the
∼1015 member randomer library, see Supplementary Mate-
rials–Note 1) from IDT (Coralville, IA); NEBNext Fast Li-
brary Prep Set for Ion Torrent kit from New England Biolabs
(Ipswich, MA); Agencourt AMpure XP from Beckman Coul-
ter (Brea, CA); Ethyl Alcohol from Fisher Scientific (Pitts-
burgh, PA); and DNA Reagent kit from Agilent Technologies
(Santa Clara, CA).
Capillary electrophoresis
We prepared “Tris–HCl sample buffer” (pH 8.2, 50 mM Tris)
and “Tris–Gly separation buffer” (pH 8.2, 31 mM Tris and
500 mM Gly). The Tris–HCl sample buffer was the leading
electrolyte (chloride anion was the leading ion), and the Tris–
Gly separation buffer was the terminal electrolyte (glycine
anion was the terminal ion). We filtered all buffers (0.20 μm
filter) prior to use. We labeled DNA “on-column” with SYBR
gold/Tris–Gly separation buffer (1:100,000). We prepared
stock DNA and thrombin samples (2 μM) in Tris–HCl sample
buffer and heated the stock DNA for 5 min at 95 °C and
allowed it to cool slowly to room temperature. We prepared
working samples by diluting stock solutions to the appropriate
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concentration with Tris–HCl sample buffer. We incubated
DNA samples with thrombin for 20 min at 4 °C prior to
injection. Incubation of samples at room temperature (25 °C)
may be beneficial for maximum complex formation [11].
However, under our experimental conditions, we observed
no differences in the amount of complex formed as a function
of incubation temperature (data not shown). Thus, for consis-
tency, we refrigerated all samples at 4 °C until analysis.
We performed all CE studies on a Beckman Coulter P/ACE
MDQ CE System with laser-induced fluorescence (LIF) de-
tection (Ar-ion laser excitation at 488 nm, 520 nm long pass,
and 488 nm notch filters). We used 32 KARAT software for
CE control and analysis. The capillary was an uncoated fused-
silica capillary (Polymicro Technologies, Phoenix, Arizona,
60.2 cm total length, 50.0 cm effective length, from inlet to
detector, and 75 μm internal diameter). We filled the capillary
and the inlet and outlet vials, with Tris–Gly separation buffer.
The collection vial contained 10 μL of 400 nM thrombin
protein in Tris–HCl sample buffer. We injected samples onto
the capillary for 4 s at 5 psi, separated at 18.0 kV, and collected
at 10 kV.
After testing 100, 200, 400, 600, 800, and 1000 nM throm-
bin against 200 nM aptamer, we concluded that 400 nM
thrombin was optimal for detection and resolution. We pre-
pared the spiked randomer library by mixing 29mer thrombin
aptamer (2 nM) and randomer (200 nM) in Tris–HCl sample
buffer and incubated it for 30 min with 400 nM thrombin.
Each day, we ran this mixture in triplicate to identify the
collection window (see ESM Fig. S1). We adjusted the
collection window as needed to account for day-to-day vari-
ations in migration time.We collected aptamer-thrombin com-
plex peak and unbound DNA peak in 16 successive runs over
4 h.We gently vortexed each volume collected to homogenize
the sample and then we stored the samples at 4 °C until NGS
analysis.
Each day, we injected 0.5, 2.5, 10, and 25 nM aptamer
standards prepared in Tris–HCl sample buffer and containing
400 nM thrombin protein onto the capillary (n=3) and con-
structed a calibration plot based on peak area. With this
calibration curve, we determined the concentrations of the
collected and re-injected samples (n=3).
Each injection of 180 nL of 200 nM randomer DNA
contained 2.16×1010 oligos (i.e., 3.46×1011 for 16 runs),
which is 1/3000th of the ∼1015 member randomer library.
NGS preparation, measurement, and analysis
We amplified the samples (“original,” “complex,” and “free”)
using NEBNext Fast DNA Library Prep Set reagents with
1 nMDNA PCR reactionmix, 10μMeach of IDT Ion Torrent
A primer, and truncated P1 primer (for PCR conditions, see
Supplementary Materials–Note 2). We cleaned up samples
using Agencourt AMPure XP (protocol 000387v001), and
we analyzed the samples for size and concentration on an
Agilent 2100 Bioanalyzer.
We performed bead preparation and sequencing according
to the Ion PGM user guides, Catalog Number 4480974, Pub-
lication Number MAN0007220, Revision 4.0 (using 10 pM
Fig. 1 Flow chart for CE
selection study. Step 1: A mixture
of thrombin aptamer, randomer,
and thrombin protein is prepared,
with aptamer concentration far
lower than either randomer or
protein. Step 2: The mixture is
injected onto the capillary,
separated, and both the aptamer-
target complex peak and the
unbound DNA peak are collected.
Step 3: Fractions are loaded onto
a sequencing chip (inset: 30 μm×
50 μm fluorescent image of Ion
Torrent’s bead-based sequencing
platform). Step 4: Bioinformatics
analysis of CE selection, which
shows an average increase in
aptamer content from 0.4 to 15 %
(see Electronic supplementary
material (ESM) Table S1)
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DNA in the OneTouch2) and Catalog Number 4482006,
Publication Number, MAN0007273, Revision 1.0
respectively.
We used NGS to characterize the efficiency of CE selection
of the 29mer aptamer based on the overrepresentation of its
sequence in the complex fraction relative to the original pre-
pared library sample. Since direct pattern search is affected by
sequencing errors, e.g., insertions/deletions, we implemented
a Smith-Waterman algorithm using MatLab (Natick, MA)
running on the DEAC computer cluster at Wake Forest Uni-
versity. We also analyzed the sequence frequency using the
extract and count function in the CLC Genomics Workbench
(CLC bio, Aarhus, Denmark). We trimmed the first 15 nucle-
otides of all the reads to remove the common spacer sequence
present in the library between the 29mer and the Ion Torrent
Primer A.
Results and discussion
Previous work optimized the ctITP method by using SYBR
Gold as an on-column, noncovalent label for single-stranded
DNA (see ESM Fig. S2) and obtained Kd=124±6 nM for
aptamer-thrombin dissociation [7], which is consistent with
publishedKd values for the 29mer [11, 12]. This demonstrated
that neither on-column labeling nor ctITP focusing interfered
with aptamer-thrombin binding and that the Ion Torrent
adapters did not unduly affect aptamer affinity.
The 29mer folds into a G-quadruplex/partial duplex struc-
ture [13]. One study found that K+ ions increased the circular
dichroism signal of the aptamer at the wavelength associated
with G-quadruplex structure [14]. However, other CE analy-
ses have concluded that K+ either did not increase complex
formation [10, 11] or that K+ or Mg2+ decreased complex
formation [10]. Given these mixed results, we studied the
effect that co-ions have on aptamer binding. We injected
200 nM 29mer and 200 nM thrombin onto the capillary either
in the absence or presence of 10 mM Mg2+, Na+, or K+ (see
ESM Fig. S3). Our addition of a co-ion resulted in decreased
fluorescence signal and shifts in migration time. Na+ and K+
had the added disadvantage of decreased resolution between
the complex and free DNA bands, which is consistent with a
CE study reporting fluorescence decreases in the presence of
K+ andMg2+ [10]. Moreover, all co-ions resulted in decreased
resolution (ESM Fig. S3). Therefore, we conducted our stud-
ies in the absence of any metal ions.
Injecting a 1:100 mixture of 29mer/randomer onto the
capillary resulted in a single peak at 7.6 min in the electro-
pherogram (Fig. 2a). When thrombin was added, we observed
increased intensity from 6.3 to 7.2 min (circles, Figs. 2b, c)
and a shoulder at 7.2 min (stars, Figs. 2b, c). Control exper-
iments with the randomer only plus thrombin revealed a
shoulder at 7.2 min (Fig. 2c, red trace) and with a sample of
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Fig. 2 Electropherograms from CE aptamer selection. a A single peak is
observed for an injection of the 1:100 DNA mixture (2 nM aptamer,
200 nM randomer). b When thrombin (400 nM) is added to the 1:100
mixture, two new signals are observed as indicated by the circle and star.
The signal indicated by the circle in b has the same migration time as the
specific aptamer-thrombin complex peak (left green peak in c), while the
peak indicated by the star in b has the same migration time as the
nonspecific “complex” peak observed between the randomer library
and thrombin (left red peak in c)
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(Fig. 2c, green trace). This peak, corresponding to the com-
plex between 29mer and thrombin, was used to establish the
collection windows (as illustrated in ESM Fig. S1) and dem-
onstrates the resolving power of CE to distinguish specific
(29mer/protein; circle, Fig. 2c, blue trace) from non-specific
(random DNA/protein; star, Fig. 2c, blue trace) interactions.
A histogram of matched bases before and after CE selec-
tion reveals that the 29mer was well selected (see Fig. S4). We
used three different groups of penalty scores (see Supplemen-
tary Materials–Note 3) in the Smith-Waterman algorithm (lo-
cal alignment gave similar results, Figs. S5-6). We chose 24
matching bases as the threshold to judge whether a measured
sequence corresponds to the 29mer. However, except for the
first run in Fig. S7 (Set 1–complex), the ratio of 29mer-to-
28mer sequences generally exceeded 90 %.
Our figure of merit is the enrichment factor, fE, defined as:
f E ¼
fraction of aptamer sequences in complex peak
fraction of aptamer sequences in original injected signal
: ð1Þ
The numerator of Eq. (1) represents the number of aptamer
sequences identified in the collected complex sample (region I
in ESM Fig. S1) divided by the total number of sequencing
reads (aptamer and non-aptamer). The denominator is the
number of aptamer sequences identified in the original library
sample (the 1:100 aptamer/randomer mixture) divided by the
total number of sequencing reads. This enrichment factor is
given in Table S1 for all of our experimental runs (refer also to
Fig. 2 and ESM S1). Each CE run exhibited enrichment,
although the magnitude of the enrichment varied 6- to 93-
fold with an average enrichment of 38.
The ability of CE to select target-binding candidate mole-
cules makes it a potentially powerful tool to discover aptamers
and other drug candidates, as can be seen in Fig. 2. The
complex/free ratio (red trace, Fig. 2b, circle vs. right-most
peak and starred peak) averages 0.88 %, close to the original
1 % aptamer concentration. However, with 2 nM aptamer,
400 nM thrombin, and Kd=124 nM, only 76 % of the
aptamers should be bound, so the complex peak should be
∼¾ aptamer and ∼¼ other DNA. Thus the fraction of complex
in the complex peak ~ 0.88 % is close to the expected value of
0.76 % based on our concentrations and the binding constant.
Averaging column 2 in Table S1(ESM) yields 0.39 %
aptamer content in the starting library sample, which is an
efficiency of 39 % (since we measured 0.39 % instead of the
expected 1 %), so, in a library with 1000 copies of each
member, 390 strands of a strong binding (Kd<<124 nM)
aptamer will be amplified for sequencing. If the CE enhance-
ment factor is 38, only 1000/38=26 strands of any other
library member would be amplified for sequencing in the
collected complex sample. This means the probability for
proper identification of a strong binder in a collected CE
fraction via NGS is extremely high, virtually 100 %. Such
an extensive overrepresentation of one sequence among many
demonstrates the robustness of this combined technique in
finding new aptamers.
The two sample runs in “Set 3” (ESM Table S1) indepen-
dently went through the process of emulsion PCR on the Ion
Torrent One Touch, enrichment of templated beads, and load-
ing onto different sized chips. Set 3a was loaded onto a 316
chip (six million wells), and Set 3b was loaded onto a 314 chip
(one million wells). The results in Table S1 (ESM) show that
there was no bias introduced by the different chips or sample
prep. Hence, the One Touch, enrichment module, and PGM
are a reliable means to investigate an aptamer DNA library for
drug discovery.
Conclusions
In summary, we have described a combined CE and NGS
system that can be used for aptamer-based molecular/drug
discovery. This paper reports on the efficacy and efficiency
of using CE as a library enrichment tool for aptamer selection
using the NGS system. Our experiments demonstrate, for the
first time, that capillary transient isotachophoresis (ctITP)-
based nonequilibrium capillary electrophoresis of equilibrium
mixtures (NECEEM) is an excellent CE modality for our
selection purposes. We showed that a single round of CE
selection can, on average, enrich an aptamer-randomer mix-
ture from 0.4 to >15 %. This level of enrichment will enable
the NGS platform to resolve, with very high probability, the
best aptamers for targets of interest in a variety of applications,
including the discovery of new drug candidates and diagnostic
reagents. The small sample volume requirement and high
degree of enrichment make CE an ideal selection technique
to aid NGS-based aptamer and drug discovery. Furthermore,
based on a previous application [15] of NGS to determine
aptamer-protein binding constants, we envision a novel “re-
versed-order” aptamer discovery approach, where an oligonu-
cleotide library would first be sequenced by next-generation
sequencing followed by exposure of the chip to a labeled
target for identification of target-binding sequences. In this
approach, CE could serve as a preselection tool to reduce the
size of the candidate library followed by on-chip NGS se-
quence identification and selection. In either case—traditional
CE-SELEX followed by NGS analysis of the obtained se-
quences or a novel reversed-order approach in which CE is
used as a preselection technique followed by on-chip aptamer
selection—CE coupled with Ion Torrent NGS represents a
powerful combination for aptamer selection.
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